Cargando…
Improving the Solubility and Bioavailability of Pemafibrate via a New Polymorph Form II
[Image: see text] Pemafibrate is a new generation of anti-hyperlipidemia drugs. However, its poor solubility in water (0.410 mg/mL at 25 °C) has limited its oral bioavailability. In this study, we aimed to improve the solubility and consequently the oral bioavailability of pemafibrate via a new poly...
Autores principales: | Li, Long, Yin, Xian-Hong, Diao, Kai-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557989/ https://www.ncbi.nlm.nih.gov/pubmed/33073151 http://dx.doi.org/10.1021/acsomega.0c04005 |
Ejemplares similares
-
Improving the solubility and bioavailability of anti-hepatitis B drug PEC via PEC–fumaric acid cocrystal
por: Li, Long, et al.
Publicado: (2020) -
Polymorph Impact on the Bioavailability and Stability of Poorly Soluble Drugs
por: Censi, Roberta, et al.
Publicado: (2015) -
Dehydroepiandrosterone Cocrystals with Improved Solubility and Bioavailability
por: Jiang, Yihua, et al.
Publicado: (2022) -
Pemafibrate Prevents Rupture of Angiotensin II-Induced Abdominal Aortic Aneurysms
por: Amioka, Naofumi, et al.
Publicado: (2022) -
Improving the Solubility, Dissolution, and Bioavailability of Metronidazole via Cocrystallization with Ethyl Gallate
por: Li, Jinhui, et al.
Publicado: (2021)